Volker Ast

1.4k total citations
18 papers, 218 citations indexed

About

Volker Ast is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Volker Ast has authored 18 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Volker Ast's work include SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (3 papers) and Immune cells in cancer (3 papers). Volker Ast is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), SARS-CoV-2 detection and testing (3 papers) and Immune cells in cancer (3 papers). Volker Ast collaborates with scholars based in Germany, Canada and Israel. Volker Ast's co-authors include Verena Haselmann, Michael Neumaier, Rainer König, Maximilian Kittel, Marcus Oswald, Stefan B. Eichmüller, Jochen Utikal, Daniel Novak, Roman Wölfel and Victor Costina and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Journal of Clinical Microbiology.

In The Last Decade

Volker Ast

17 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Volker Ast Germany	10	86	57	47	44	32	18	218
Gabriele Büchel Germany	6	151 1.8×	40 0.7×	23 0.5×	23 0.5×	50 1.6×	10	238
Fengxia Gao China	8	129 1.5×	61 1.1×	59 1.3×	121 2.8×	13 0.4×	17	311
Verena van der Heide United States	9	90 1.0×	41 0.7×	55 1.2×	138 3.1×	7 0.2×	18	292
Н. А. Никитенко Russia	8	111 1.3×	21 0.4×	28 0.6×	15 0.3×	12 0.4×	16	167
Yanwen Xu China	5	107 1.2×	70 1.2×	38 0.8×	82 1.9×	10 0.3×	11	232
Romy Kronstein‐Wiedemann Germany	7	72 0.8×	104 1.8×	11 0.2×	49 1.1×	27 0.8×	17	297
Yanjun Lai China	3	102 1.2×	171 3.0×	75 1.6×	45 1.0×	95 3.0×	9	309
Roberta Ragazzini United Kingdom	6	222 2.6×	42 0.7×	116 2.5×	35 0.8×	11 0.3×	8	319
Gardenia Vargas‐Parra Spain	6	76 0.9×	56 1.0×	39 0.8×	40 0.9×	8 0.3×	10	186
Vrinda Hershberger United States	7	108 1.3×	37 0.6×	9 0.2×	18 0.4×	13 0.4×	12	329

Countries citing papers authored by Volker Ast

Since Specialization

Citations

This map shows the geographic impact of Volker Ast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Ast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Ast more than expected).

Fields of papers citing papers by Volker Ast

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Ast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Ast. The network helps show where Volker Ast may publish in the future.

Co-authorship network of co-authors of Volker Ast

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Ast. A scholar is included among the top collaborators of Volker Ast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Ast. Volker Ast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kurt, Feyza Gül Özbay, Carolina De La Torre, Volker Ast, et al.. (2024). S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. Journal for ImmunoTherapy of Cancer. 12(9). e009552–e009552. 16 indexed citations

Jeong, Mingeum, Carolina De La Torre, Volker Ast, et al.. (2023). Liver sinusoidal endothelial cells orchestrate NK cell recruitment and activation in acute inflammatory liver injury. Cell Reports. 42(8). 112836–112836. 19 indexed citations

Kittel, Maximilian, Volker Ast, Peter Bugert, et al.. (2023). Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome. Viruses. 15(2). 454–454. 3 indexed citations

Haselmann, Verena, Volker Ast, Maximilian Kittel, et al.. (2023). Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients. Microorganisms. 11(7). 1740–1740. 1 indexed citations

Neumaier, Michael, Volker Ast, Eileen Reinz, et al.. (2023). Opsonization-independent antigen-specific recognition by myeloid phagocytes expressing monoclonal antibodies. Science Advances. 9(35). eadg1812–eadg1812.

Kittel, Maximilian, Volker Ast, Anja Keßler, et al.. (2022). Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application. Viruses. 14(8). 1662–1662. 4 indexed citations

Haselmann, Verena, Volker Ast, Matthias F. Froelich, et al.. (2021). Plasma-based S100B testing for management of traumatic brain injury in emergency setting. Practical Laboratory Medicine. 26. e00236–e00236. 18 indexed citations

Froelich, Matthias F., Volker Ast, Victor Costina, et al.. (2021). Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care. Molecular Oncology. 16(10). 2042–2056. 10 indexed citations

Kittel, Maximilian, et al.. (2021). Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. International Journal of Infectious Diseases. 107. 221–227. 32 indexed citations

10.

Ast, Volker, Victor Costina, Gerhard Dobler, et al.. (2021). Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection. Journal of Clinical Microbiology. 59(9). e0055921–e0055921. 7 indexed citations

11.

Krüger, Thomas, Hans‐Martin Dahse, Zoltán Cseresnyés, et al.. (2020). Functional surface proteomic profiling reveals the host heat‐shock protein A8 as a mediator of Lichtheimia corymbifera recognition by murine alveolar macrophages. Environmental Microbiology. 22(9). 3722–3740. 6 indexed citations

12.

Ast, Volker, et al.. (2020). Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks. Cells. 9(11). 2443–2443. 2 indexed citations

13.

Haselmann, Verena, Mustafa Özçürümez, Frank Klawonn, et al.. (2020). Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing. Clinical Chemistry and Laboratory Medicine (CCLM). 58(12). 2121–2130. 18 indexed citations

14.

Poos, Alexandra M., et al.. (2019). Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach. BMC Bioinformatics. 20(1). 737–737. 3 indexed citations

15.

Schnöder, Tina M., Ilse D. Jacobsen, Martina Rauner, et al.. (2019). Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation. Oncogene. 38(24). 4773–4787. 11 indexed citations

16.

Ast, Volker, Marcus Oswald, David Eisel, et al.. (2018). MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion. Oncotarget. 9(85). 35559–35580. 28 indexed citations

17.

Weber, Claudia E.M., Marcus Oswald, Volker Ast, et al.. (2016). SOX5 is involved in balanced MITF regulation in human melanoma cells. BMC Medical Genomics. 9(1). 10–10. 25 indexed citations

18.

Costa, Barbara, Michelle J. Kean, Volker Ast, et al.. (2012). STK25 Protein Mediates TrkA and CCM2 Protein-dependent Death in Pediatric Tumor Cells of Neural Origin. Journal of Biological Chemistry. 287(35). 29285–29289. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact